Remifentanil Hydrochloride For Injection; Out Of Specification (assay & Impurity)
Remifentanil hydrochloride for injection 1 mg/vial is being recalled across Canada because testing found the product did not meet required quality standards for drug purity and active ingredient content. This is a Class II recall, meaning the product could cause temporary or medically reversible health effects. The recall affects remifentanil hydrochloride injectable medication distributed nationwide in Canada.
- Product
- Remifentanil hydrochloride for injection 1 mg/vial
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-06-26
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6a784a66-ad11-4308-942e-f94dc6945173